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Abstract Atypical and melancholic subtypes of depression
based on the Diagnostic and Statistical Manual (DSM) IV
are important concepts, especially for biological psychiatry.
The aim of this study was to determine whether the symptoms
used for the diagnoses of atypical and melancholic depression
can distinguish these subtypes during pregnancy. A modified
version of the Structured Clinical Interview for DSM IV
(SCID interview) was used that allowed assessment of all
DSM IV symptoms of melancholic and atypical depression
with depressed and non-depressed women in pregnancy. A
Swiss cohort of 449 women was interviewed. Four diagnostic
groups were compared: women with melancholic, atypical or
non specified depression, and those without depression.
Seventeen per cent of the cohort met SCID criteria for a
depressive episode of depression at least once in pregnancy,
with melancholic depression 2.4%, atypical depression 4.4%
and non specified depression 10.2%. Many of the symptoms
used to distinguish atypical and melancholic depression did
not discriminate between these groups during pregnancy.
However some, such as mood reactivity, distinct quality of
mood and sleep pattern, did discriminate. Differential diag-
nosis between melancholic and atypical depression in
pregnancy needs to be based on pregnancy specific defini-
tions. The possible therapeutic consequences and the neuro-
biological basis for these findings warrant further research.
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Introduction
The melancholic and atypical subtypes of depression,
characterised as “specifiers” by the Diagnostic and Statistical
Manual (DSM IV; APA 1994) are well established. Different
responses to medication (e.g. iproniazid shows better
response to atypical depression compared to melancholic
depression (West and Dally 1959a, b)) initially led to the
concept of melancholic and atypical depression. More recent
studies have investigated treatment response in atypical as
opposed to melancholic depression, e.g. Mannel et al. 2010.
The finding that the two groups show the extremes of HPA
axis function strengthened the importance of this diagnostic
concept. Recently, psychological characteristics, e.g. the
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response to the attachment assessment (with significantly
lower secure attachment scores with atypical depression
compared to melancholic depression) hint at different
psychological aspects of the two diagnostic groups (Levitan
et al. 2009). Thus both from the perspective of optimal
medication and from that of potential associated psycholog-
ical symptoms, it may be important to characterise the nature
of depression into melancholic and atypical subtypes, during
pregnancy as well as at other times.
Dichotomised extremes of associated symptoms of
depression are used for the differential diagnosis between
melancholic depression and atypical depression: excitability
versus loss of interest, overeating versus loss of appetite,
oversleeping versus sleeping problems. In addition, symp-
toms specific for either condition are used: feelings of leaden
paralysis and rejection sensitivity are counted as specific
symptoms for the diagnoses of depression with atypical
features. For depression with melancholic features these are
that depressed mood is worse in the morning, feelings of
excessive or inappropriate guilt, symptoms of marked motor
retardation or agitation, and the distinct quality of the
depressed mood. The latter means that the depressed mood
is experienced as distinctly different from the kind of feeling
experienced after the death of a loved one.
Data from the National Comorbidity Survey (N=4,907,
Matza et al. 2003) using the Composite International
Diagnostic Interview (WHO 1990) and data from a large
American twin registry sample (N=6,846; Sullivan et al.
2002) have strengthened the evidence for the existence of
these subtypes. A recent comprehensive review by Stewart
et al. has confirmed the validity of these diagnoses (Stewart
et al. 2009). However, the reliability of these two diagnostic
concepts has never been studied in pregnancy.
There are substantial physiological changes during preg-
nancy that might affect the frequency of symptoms like sleep
and appetite problems, even among non-depressed women
(Kammerer et al. 2009). There are also major changes in the
function of the hypothalamic–pituitary–adrenal (HPA) axis
(Magiakou et al. 1997; Kammerer et al. 2002, 2006; Taylor
et al. 2009) and the hypothalamic–pituitary–gonadal axis
(Bloch et al. 2004). There is evidence that atypical
depression and melancholic depression are characterised by
different alterations in the function of the HPA axis. For
example, whereas melancholic depression is associated with
increased activity, atypical depression is associated with
reduced cortisol output (Gold and Chrousos 2002), and an
altered cortisol response to desipramine injection (Asnis
et al. 1995; Tops et al. 2008). A blunting of the cortisol
awakening response has been found in both rejection
sensitivity (Tops et al. 2008) and postpartum depression
(Taylor et al. 2009). An increased feedback function of the
hypothalamic–pituitary–adrenal (HPA) axis was found with
atypical depression in contrast to melancholic depression
(Levitan et al. 2002). However it is unknown whether these
differences are also true during pregnancy when cortisol
levels rise markedly. In pregnancy, the placenta plays a key
role by producing corticotropin releasing hormone with a
positive feedback regulation of cortisol.
We previously have reported that appetite is not a
reliable symptom of depression in pregnancy and postpar-
tum (Kammerer et al. 2009). A recent prospective study of
850 women found that loss of appetite was rare among all
postnatally depressed women (Herring et al. 2008). This
strengthens the importance of the question to what extent
differential diagnosis between melancholic and atypical
depression is reliable during the perinatal period.
In this study, our aim was to determine to what extent
the current definition of these diagnostic groups, of
melancholic and atypical depression, is useful during
pregnancy.
Method
With approval of the ethics committee of the Canton of
Zurich, Switzerland, written informed consent was obtained
from all participants. Current conditions with psychotic
features, current drug or alcohol dependency, or a general
medical condition were exclusion criteria.
The SCID interview is specifically designed to assess
diagnoses of DSM IV. In order to ascertain information
necessary for the diagnosis of a depressive episode, the
SCID interview explores symptoms experienced by the
proband in the past. In the current study, only the pregnancy
time period was assessed. Other episodes of depression that
the participating woman may have had experienced earlier in
life were not assessed. At interview (6 weeks post partum), the
worst 4 weeks in pregnancy were assessed in detail with
regard to the presence of the nine SCID symptoms of
depression, the eight symptoms of the melancholic specifier
of depression, and the five symptoms of the atypical specifier
of depression. Usually, the SCID interview regarding these
diagnoses and specifiers is finished if the interviewee
does not fulfil the entry criteria. The entry criterion for
the atypical specifier of depression is the persistence of a
positive reaction to positive stimuli and the entry criteria
for the melancholic specifier of depression are lack of a
positive reaction and/or lack of pleasure in all, or almost
all, activities. However in this study, all symptoms of
melancholic and atypical depression were assessed with
all participants irrespective of whether participants
fulfilled the entry criteria for either specifier of depres-
sion. This method has not been used before.
In order to ascertain possible differences in distribution
between the diagnostic groups, sociodemographic charac-
teristics were recorded at interview.
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Using tape-recorded interviews and repeated interviews
with 50 interviews selected at random, the interviewers'
judgement and the training psychiatrist's judgements were
correlated 0.68 to 0.82, kappa coefficient (Cohen 1960).The
interviewers' ratings were kept in the database. The
interviewers were students of psychology, psychiatric
nurses and a midwife who had been extensively trained in
a series of workshops. A consecutive sample of 449
participants was asked about all symptoms of depression
and all the melancholic and atypical symptoms of
depression in pregnancy. The sample was divided into four
diagnostic groups: depression without specifiers of
atypical or melancholic depression (D), atypical depres-
sion (AD), melancholic depression (MD) and non-
depressed participants (ND). As the melancholic and
atypical specifiers exclude each other the two subjects
who qualified for the melancholic as well as the atypical
specifier were added to the melancholic group only,
following the DSM rules.
Using SPSS 12.0, 4×2 chi-square and post hoc 2×2 chi-
square or Fisher's exact test, when cell sizes were below 6,
were used to test for the significance of differences in
proportions. One-way analysis of variance (ANOVA) was
used to compare means of normally distributed parametric
variables. Sensitivity and specificity of the individual symp-
toms of melancholic and atypical depression was calculated
(Altman and Bland 1994).
Results
There were no significant differences between the four
diagnostic groups, in age, marital status, cohabitation status,
socioeconomic status, parity, previous pregnancy loss, medi-
cation, smoking, alcohol abuse and illicit drug taking (Table 1).
Seventeen per cent (77/449) of the cohort met SCID
criteria for a depressive episode of depression at least once
in pregnancy. The percentage of subjects with an episode of
depression in pregnancy who met the criteria for the
diagnosis for melancholic depression was 2.4% (11/449),
for atypical depression 4.4% (20/449) and for non specified
depression was 10.2% (46/449).
Table 2 shows the percentage reporting each of the
melancholic symptoms in the four groups. The symptom of
anorexia did not discriminate melancholic depression from
any of the other groups. Four of the melancholic symptoms
(loss of pleasure, one of the two entry criteria), mood worse in
the morning, psychomotor retardation or agitation, excessive
and inappropriate guilt, did not discriminate melancholic from
atypical depression. Insomnia (sensitivity, 64%; specificity,
80%), and distinct quality of depressed mood (sensitivity,
100%; specificity, 35%) did discriminate melancholic from
atypical depression, as did lack of reactivity to usually Ta
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pleasurable stimuli (which by definition excludes atypical
depression; specificity, 100%; sensitivity, 45%).
Table 3 shows the percentage reporting each of the
atypical symptoms in the four groups. Three out of five
atypical symptoms did not discriminate between melancholic
depression and atypical depression. Hypersomnia emerges as
the only sufficiently sensitive (35%) and totally specific
(100%) symptom of atypical depression when comparing
atypical depression versus melancholic depression. The
criterion of mood reactivity had to be fulfilled by definition
in order to be qualified for being considered atypical.
Despite the inability of many of the specifier symptoms
to discriminate between melancholic and atypical depres-
sion, with the exception of the symptom of anorexia all
melancholic and atypical symptoms discriminate their
respective specifier from non specified depression. With
Table 2 Proportion (%) of subjects meeting criterion on individual melancholic SCID symptoms in pregnancy
SCID melancholic
symptoms
Non-depresseda
“ND”
Depressed without
specifiersb “D”
Atypical
depressedc “AD”
Melancholic
depressedd “MD”
2×4 chi-squares
or Fisher's exact
test
Post hoc tests (2×2 chi-
squares or Fisher's exact)
MD vs. AD MD vs. D MD vs. ND
Loss of pleasure 1/372 (0.003%) 18/46 (39%) 12/20 (60%) 9/11 (81.8%) p<0.001 p=0.262 ns p=0.017 p<0.001
Lack of reactivity to
usually pleasurable
stimuli
15/372 (4%) 5/46 (10.8%) 0/20 (0%) 5/11 (45.4%) p<0.001 p=0.003 p=0.017 p<0.001
Distinct quality of
depressed mood
45/372 (12.1%) 23/46 (50%) 13/20 (65%) 11/11 (100%) p<0.001 p=0.033 p=0.002 p<0.001
Mood regularly worse
in the morning
18/372 (4.8%) 4/46 (8.7%) 2/20 (10%) 5/11 (45.4%) p=0.001 p=0.67 ns p=0.009 p=0.006
Insomnia 87/372 (23.4%) 11/46 (23.9%) 4/20 (20%) 7/11 (63.6%) p=0.038 p=0.023 p=0.026 p<0.001
Psychomotor retardation
or agitation
37/372 (9.9%) 4/46 (8.7%) 10/20 (50%) 8/11 (72.7%) p<0.001 p=0.275 ns p<0.001 p<0.001
Significant anorexia
or weight loss
11/372 (3%) 3/46 (6.5%) 0/20 (0%) 0/11 (0%) p=0.445e ns na na na
Excessive or
inappropriate guilt
9/372 (2.4%) 4/46 (8.7%) 4/20 (20%) 6/11 (54.5%) p<0.001 p=0.106 ns p=0.002 p<0.001
a i.e. not fulfilling SCID criteria for a DSM IV diagnosis of a depressive episode
b i.e. fulfilling SCID criteria for a DSM IV diagnosis of depression
c i.e. fulfilling SCID criteria for a DSM IV diagnosis of an atypical specifier of depression
d i.e. fulfilling SCID criteria for a DSM IV diagnosis of a melancholic specifier of depression
e A post hoc 2×2 test for the item anorexia is not applicable as Fisher’s exact 2×4 test provided a non significant result
Table 3 Proportion (%) of subjects meeting criterion on individual atypical SCID symptoms in pregnancy
SCID atypical symptoms Non-depresseda
“ND”
Depressedb
“D”
Atypical depressedc
“AD”
Melancholic
depressedd “MD”
Fisher's exact
test
Post hoc tests (2×2 chi-
squares or Fisher's exact)
AD vs. MD AD vs. D AD vs. ND
Mood reactivity: entry
criterion
347/372 (93.3%) 37/46 (80.4%) 20/20 (100%) 5/11 (45.4%) p<0.001 p=0.001 p=0.048 p=0.628
ns
Weight gain or increase
in appetite
146/372 (39.2%) 14/46 (30.4%) 17/20 (85%) 7/11 (63.6%) p<0.001 p=0.21 p<0.001 p<0.001
ns
Hypersomnia 33/372 (8.9%) 6/46 (13%) 7/20 (35%) 0/11 (0%) p=0.006 p=0.033 p=0.05 p=0.002
Leaden paralysis 101/372 (29.2%) 6/46 (13%) 13/20 (65%) 7/11 (63.6%) p<0.001 p=1.0 p<0.001 p=0.001
ns
Interpersonal rejection
sensitivity
74/372 (19.9%) 12/46 (26.1%) 14/20 (70%) 7/11 (63.6%) p<0.001 p=1.0 p=0.001 p<0.001
ns
a i.e. not fulfilling SCID criteria for a DSM IV diagnosis of a depressive episode
b i.e. fulfilling SCID criteria for a DSM IV diagnosis of depression
c i.e. fulfilling SCID criteria for a DSM IV diagnosis of an atypical specifier of depression
d i.e. fulfilling SCID criteria for a DSM IV diagnosis of a melancholic specifier of depression
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the exception of anorexia and mood reactivity all melan-
cholic and atypical symptoms discriminate their respective
specifier from the non-depressed group.
Discussion
Since West and Dally (1959a, b) proposed the term atypical
depression in 1959 to describe a type of depression that
differed in its symptom profile and response to drug
treatment (iproniazid) from other depression, their sugges-
tion has been widely confirmed. Treatment response
characteristics with non pregnant patients (Quitkin et al.
1988, 1990; Stewart et al. 1997) and epidemiological data
show that the melancholic and atypical specifiers are well
established. From a lifetime perspective, a longitudinal overlap
of melancholic and atypical depression has been reported
(Angst et al. 2007).These authors stress that the longitudinal
overlap of melancholia with atypical depression in almost half
of all cases may call for comparative analyses of combined,
pure and unspecified major depressive episodes.
The identification and validation of these distinct depressive
syndromes outside pregnancy can be considered as very well
confirmed (Kendler et al. 1996; Kendler 1997). However, in
the current study many of the symptoms used outside
pregnancy did not distinguish atypical and melancholic
episodes in pregnancy. Because of the well recognised issue
that the biological signs of pregnancy were sometimes
confounded with symptoms of depression a specific screening
instrument for depression has been developed for the
peripartum, i.e. the Edinburgh Postnatal (sometimes now also
called Perinatal) Depression Scale (Cox et al. 1987). We have
provided further evidence for this; the DSM IV definition of
depression when used in the peripartum needs adaptations
(Kammerer et al. 2009). The current study shows that this
applies for the melancholic and atypical specifiers when used
in pregnancy as well.
This study benefits from the sample under study being
consecutive women giving childbirth. However the sample
size of the depressed subgroups, and the retrospective nature
of the SCID interviews and that the SCID interviews have not
been exclusively conducted bymental health professionals (as
one of the interviewers was a midwife), are limitations. It is
possible that this may have resulted in the high level of 17%
with a SCID diagnosis of depression at least once in
pregnancy. However this level is comparable with some other
studies. Gavin et al. (Gavin et al. 2005) report combined point
prevalence estimates from meta-analyses with a range from
6.5% to 12.9% at different trimesters of pregnancy whereas
our interviewers assessed the prevalence throughout all three
trimesters of pregnancy.
In this study, the proportion of atypical depression (20/77;
26%) in our sample of depressed pregnant women is
significantly smaller (χ2=103.8, p<0.0001) than the per-
centage reported by Matza et al. (Matza et al. 2003; 304/835;
36.4%) from his general sample of depressed participants.
His sample was drawn from the National Comorbidity Survey
and they were both male and female (the females without
definition of their perinatal or non perinatal status). However,
the proportion of atypical depression in our whole sample of
449 subjects including depressed with and without specifiers
and non-depressed (20/449; 4.5%) is not significantly different
in size compared with the data reported by Sullivan et al. from a
twin registry cohort (Sullivan et al. 2002; 176/5882; 3%, χ2=
2.761, p=0.1 NS). Consequently, there is no clear evidence
that the overall rates are influenced by pregnancy.
In a representative sample of 800 women in Gothenburg,
aged 38–54 years, the point prevalence of major depressive
episode according to DSM-III criteria was 6.9%. Of these,
2.9% had a melancholic episode and 4.0% a non-melancholic.
Unfortunately, the authors did not further disentangle the “non
melancholic” group into those suffering from atypical
depression and those suffering from unspecified depression.
Therefore, comparison with our study is limited. However,
their findings (Hallstrom 1984) support the abovementioned
conclusion that there is so far no clear evidence that the
overall rates of melancholic and atypical depression are
influenced by pregnancy.
In summary, the results of this study show that some
symptoms used to diagnose atypical and melancholic
specifiers of depression did not distinguish these groups
from each other during pregnancy. Therefore, adaptation of
the definitions of the specifiers of melancholic and atypical
depression for use in pregnancy appears to be necessary. It
may also be worthwhile considering the use of diagnoses of
combined, pure and unspecified major depressive episodes
as suggested by Angst et al. in view of their longitudinal
data (Angst et al. 2007). The specified atypical and
melancholic depression groups and the combined groups
of these two might benefit from different kinds of treatment
and medication than those who suffer from unspecified
depression alone. More research, including into the possible
neurobiological causes and underpinnings, is warranted.
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